Clinical Trials

23 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

GastrointestinalGenitourinaryThoracic

300 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

NCT05875870 2026-02-17

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

200 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT06195527 2026-01-06

PEMBRO-K

75 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07320105 2026-01-06

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Phase 4 Recruiting

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07279402 2025-12-12

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07244016 2025-11-24

ES-SCLC

40 enrolled

Small Cell Lung Carcinoma

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Phase 3 Recruiting

190 enrolled

Asymptomatic Brain Metastases

NCT05277844 2025-09-10

TARGET-01

106 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05278052 2025-09-10

TARGET-02

Phase 3 Recruiting

190 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06322329 2025-09-02

RealMove(lung)

150 enrolled

Lung Neoplasms

NCT07131163 2025-08-20

NoSurgery

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

36 enrolled

Unresectable Non-small Cell Lung Cancer

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

123 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

GastrointestinalGenitourinaryThoracic

40 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT07039994 2025-06-26

AIRPAL

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06959173 2025-05-06

Organoid-guided Personalized Treatment of Pleural Effusion

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

NCT06939049 2025-04-22

SISTEMA

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

60 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06796816 2025-01-28

BIVA-18

1,000 enrolled

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT06249854 2024-10-01

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

45 enrolled

Small Cell Lung Carcinoma

NCT06479473 2024-08-09

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

150 enrolled

Small Cell Lung Carcinoma

NCT06531460 2024-08-01

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

310 enrolled

Infections, Lung Neoplasms

NCT05269485 2024-06-25

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

36 enrolled

Phase EARLY_PHASE1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06436885 2024-05-31

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

39 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05878028 2024-05-23

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06406608 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06406660 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT05377658 2024-02-21

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06188650 2024-01-03

The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05832827 2023-10-23

Artemis

35 enrolled